| Wang, Dong |
NCT06704334: The Study of Ginkgo Leaf Dropping Pills and Huperzine a Injection Combined with Median Nerve Electrical Stimulation in the Treatment of Cognitive Impairment After Brain Injury |
|
|
| Recruiting | 4 | 50 | RoW | Median nerve electrical stimulation treatment, Huperzine A injection, Ginkgo leaf dropping pill | Wanbangde Pharmaceutical Group Co., LTD, Ganzhou City People's Hospital | Cognitive Impairment After Brain Injury | 12/26 | 12/26 | | |
| Completed | 3 | 1412 | RoW | Injection of recombinant human tissue plasminogen kinase derivatives, Reteplase, brand name: Ruitongli, r-PA, Recombinant human tissue plasminogen activator, Alteplase, brand name: Actilyse, rt-PA | Angde Biotech Pharmaceutical Co., Ltd., Beijing Tiantan Hospital | Acute Ischemic Stroke | 06/23 | 06/23 | | |
| Not yet recruiting | 3 | 420 | RoW | Anlotinib hydrochloride capsule + TQB2450 injection, Chemotherapy drug | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Endometrial Cancer | 12/27 | 06/29 | | |
NCT06584032: Study of Fruquintinib Plus Sintilimab for Treatment of Advanced Endometrial Cancer |
|
|
| Recruiting | 3 | 412 | RoW | fruquintinib, HMPL-013, sintilimab, IBI308, paclitaxel, doxorubicin | Hutchmed | Advanced Endometrial Cancer | 01/29 | 06/29 | | |
NCT04060459: Paclitaxel-binding Albumin and Cisplatin as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer |
|
|
| Recruiting | 2 | 50 | RoW | Paclitaxel-binding albumin | Third Military Medical University | Bladder Cancer | 10/20 | 10/22 | | |
TQB2450-II-08, NCT04574284: A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Subjects With Advanced Endometrial Cancer |
|
|
| Recruiting | 2 | 196 | RoW | TQB2450, Anlotinib | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Endometrial Cancer | 12/21 | 04/22 | | |
TQB3616-ALTN-II-01, NCT04924192: A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer |
|
|
| Recruiting | 2 | 126 | RoW | TQB3616 capsules, Anlotinib Hydrochloride capsules, Irinotecan Hydrochloride for Injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Lung Carcinoma | 05/23 | 12/23 | | |
NCT06421688: Effect of Vitamin C on Postoperative Pulmonary Complications After Intracranial Tumor Surgery |
|
|
| Not yet recruiting | 2 | 86 | RoW | Ascorbic acid, vitamin C, Saline, saline (medicine) | Qianfoshan Hospital | Ascorbic Acid, Neurosurgical Procedures, Humans, Ventilator-Induced Lung Injury, Postoperative Complications | 01/25 | 06/25 | | |
NCT05892237: CIETAI and Sequential Radiotherapy in Squamous Lung Cancer |
|
|
| Recruiting | 2 | 50 | RoW | bronchial artery interventional therapy, Chemotherapy drug, IMRT, Immunotherapy | Dong Wang | Carcinoma, Non-Small-Cell Lung | 02/25 | 06/26 | | |
NCT05686642: Efficacy and Safety of LT3001 on Treating the Acute Ischemic Stroke |
|
|
| Recruiting | 2 | 300 | RoW | LT3001 Drug:high dose, Placebo, LT3001 Drug:low dose | Shanghai Pharmaceuticals Holding Co., Ltd | Acute Ischemic Stroke | 04/25 | 07/25 | | |
NCT05957016: Neoadjuvant CIETAI With Concurrent Chemoradiotherapy in Local Advanced Rectal Cancer |
|
|
| Recruiting | 2 | 90 | RoW | CIETAI-R | Third Military Medical University | Rectal Cancer | 06/25 | 06/26 | | |
KL264-01, NCT04152499: Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies |
|
|
| Recruiting | 1/2 | 1300 | Canada, US, RoW | SKB264 | Klus Pharma Inc. | Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Small-Cell Lung Cancer, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Breast Cancer | 08/25 | 07/26 | | |
ALT-SCLC-02, NCT04731909: Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer |
|
|
| Recruiting | N/A | 80 | RoW | Toripalimab, Toripalimab Injection, Teruipuli dankang Zhusheye, TuoYI, JS001, Anlotinib, Anlotinib Hydrochloride Capsules, FuKeWei, Cisplatin, Cisplatin injection, Carboplatin, Carboplatin injection | Third Military Medical University | SCLC, Extensive Stage, Lung Cancer, Small Cell Lung Cancer | 06/22 | 06/23 | | |
NCT04471480: TC Plus PD-1 Inhibitors Combined With Anlotinib for Advanced Advanced Esophageal Cancer |
|
|
| Not yet recruiting | N/A | 90 | RoW | TC/PD-1 inhibitor/anlotinib, TC/PD-1 inhibitor | Dong Wang | ESCC | 08/22 | 08/23 | | |
NCT06686134: Comprehensive Clinical Evaluation Study of GLP-1RA |
|
|
| Recruiting | N/A | 492 | RoW | | LI YAN | T2DM | 12/25 | 07/26 | | |
NCT03358602: Radiotherapy vs Neck Dissection for Clinical T1/2N0 Supraglottic Cancer |
|
|
| Not yet recruiting | N/A | 158 | RoW | Radiotherapy, Selective neck dissection | Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University General Hospital, Tianjin Medical University Second Hospital | Supraglottic Cancer | 11/25 | 11/27 | | |
NCT04989153: Nasal Endoscopic Screening and Risk Assessment for Early Gastric Cancer |
|
|
| Recruiting | N/A | 5000 | RoW | pepsinogen | Second Affiliated Hospital, School of Medicine, Zhejiang University, Jilin City People's Hospital, No. 924 Hospital of the People's Liberation Army of China, Kunshan Hospital of Traditional Chinese Medicine, Chinese PLA General Hospital, Sichuan Provincial People's Hospital, Affiliated Hospital of Southwest Medical University, Zhongshan Hospital Xiamen University, Jingzhou Hospital of Traditional Chinese Medicine, Changhai Hospital | Gastric Cancer, Precancerous Lesion, Helicobacter Pylori Infection | 12/22 | 12/23 | | |
| Zhang, Lun |
NCT03358602: Radiotherapy vs Neck Dissection for Clinical T1/2N0 Supraglottic Cancer |
|
|
| Not yet recruiting | N/A | 158 | RoW | Radiotherapy, Selective neck dissection | Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University General Hospital, Tianjin Medical University Second Hospital | Supraglottic Cancer | 11/25 | 11/27 | | |
